Programmatic Implementation and Technical Assistance (TA) for HIV/AIDS and Tuberculosis (TB) Prevention, Care, and Treatment Services throughout the Health System in South Africa under the President’s Emergency Plan for AIDS Relief (PEPFAR)” | CDC RFA GH16 164302CONT17

Opportunity Information: Apply for CDC RFA GH16 164302CONT17

This funding opportunity is a continuation cooperative agreement issued by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), specifically through CDCs Center for Global Health. It supports work in South Africa under the President's Emergency Plan for AIDS Relief (PEPFAR) and focuses on both programmatic implementation and technical assistance for HIV/AIDS and tuberculosis prevention, care, and treatment services across the broader health system. In practical terms, the grant is designed to help sustain and strengthen real-world service delivery while also improving the systems, skills, and operational approaches needed to run high-quality HIV and TB programs at scale.

The opportunity is identified as Funding Opportunity Number CDC RFA GH16 164302CONT17, with a funding activity category listed as Health and a CFDA number of 93.067. The mechanism is a cooperative agreement, which typically means the CDC expects to have substantial involvement during the period of performance rather than acting only as a funder. Cooperative agreements often include close collaboration on planning, monitoring, performance improvement, reporting, and alignment with national strategies and PEPFAR priorities. The word "continuation" also signals that this announcement is meant to extend or continue ongoing work rather than launch a completely new initiative, usually to maintain momentum, protect prior investments, and ensure continuity of critical services.

The programmatic scope centers on HIV and TB services "throughout the health system" in South Africa. That phrasing generally implies a broad, system-wide approach rather than isolated projects in a single clinic or district. It suggests efforts that can span prevention (such as HIV testing services, prevention programming, and TB screening), clinical care and treatment (including linkage to care, initiation and maintenance of antiretroviral therapy, TB treatment integration, and clinical monitoring), and support functions that keep programs functioning effectively (like supply chain support, data systems strengthening, quality improvement, and workforce capacity building). Because HIV and TB are closely linked in South Africa, especially given the high burden of TB among people living with HIV, this opportunity explicitly pairs the two diseases and points toward integrated programming and coordinated service delivery.

A central feature of the award is technical assistance, which usually refers to expert support aimed at improving how services are planned, delivered, measured, and sustained. In PEPFAR-supported programs, TA frequently includes activities like strengthening clinical mentorship and supportive supervision, improving case finding and linkage strategies, building capacity for routine program monitoring and evaluation, supporting implementation of national guidelines, and improving the use of data for decision-making at facility, district, and provincial levels. TA also often involves developing or refining standard operating procedures, training curricula, and performance management approaches, with the goal of leaving behind stronger local systems rather than parallel structures.

The announcement indicates an expectation of up to 10 awards. The award ceiling is listed as 0, which commonly indicates that a specific maximum dollar amount is not being stated in the summary field, not necessarily that no funds are available. In many federal postings, a zero ceiling can reflect that budgets are negotiated based on the continuation context, available appropriations, and program priorities rather than a single fixed cap. Applicants typically need to align proposed activities with CDC and PEPFAR priorities and demonstrate measurable impact, feasibility, and the ability to coordinate effectively with South Africas Department of Health and other implementing partners.

Eligibility is described broadly as "Others" with direction to consult the additional eligibility text in the full announcement for clarification. In CDC cooperative agreements of this type, eligible applicants often include non-governmental organizations, universities, public or private institutions, and sometimes other entities with demonstrated capacity to implement large-scale public health programs and provide technical assistance in partnership with government health services. Because this is a continuation opportunity, eligibility and competitiveness may be influenced by existing awards, prior performance, and the structure of the ongoing program portfolio.

Key administrative details included in the posting are the creation date of February 8, 2017 and an original closing date of April 11, 2017. The agency is listed as the Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), and the opportunity is clearly situated within PEPFAR programming in South Africa. Overall, the grant is aimed at maintaining and improving comprehensive HIV and TB prevention, care, and treatment services by combining direct implementation support with hands-on technical assistance that strengthens the health system and supports sustained outcomes at population scale.

• The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Programmatic Implementation and Technical Assistance (TA) for HIV/AIDS and Tuberculosis (TB) Prevention, Care, and Treatment Services throughout the Health System in South Africa under the President’s Emergency Plan for AIDS Relief (PEPFAR)”" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on Feb 08, 2017.
• Applicants must submit their applications by Apr 11, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 10 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA GH16 164302CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: